✦ LIBER ✦

Clinical experience with oral sumatriptan: a placebo-controlled, dose-ranging study

✍ Scribed by J. P. Patten

Publisher: Springer
Year: 1991
Tongue: English
Weight: 374 KB
Volume: 238
Category: Article
ISSN: 0340-5354
DOI: 10.1007/bf01642909

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Treatment of psoriasis with oral liarozo

Treatment of psoriasis with oral liarozole: a dose-ranging study

✍ J. Berth-Jones; G. Todd; P.E. Hutchinson; K. Thestrup-Pedersen; F.P. Vanhoutte 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 422 KB

Managing migraine headaches experienced

Managing migraine headaches experienced by patients who self–report with menstrually related migraine: a prospective, placebo–controlled study with oral sumatriptan

✍ A. J. Dowson; H. Massiou; S. K. Aurora 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 57 KB

Golimumab in patients with active rheuma

Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 133 KB 👁 2 views

Erratum: Golimumab in patients with acti

Erratum: Golimumab in patients with active rheumatoid arthritis despite treatment with methotrexate: A randomized, double-blind, placebo-controlled, dose-ranging study

✍ Jonathan Kay; Eric L. Matteson; Bhaskar Dasgupta; Peter Nash; Patrick Durez; Ste 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 30 KB 👁 2 views

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National

Hydrazine sulfate in cancer patients wit

Hydrazine sulfate in cancer patients with weight loss. A placebo-controlled clinical experience

✍ Rowan T. Chlebowski; Linda Bulcavage; Mary Grosvenor; Raynelle Tsunokai; Jerome 📂 Article 📅 1987 🏛 John Wiley and Sons 🌐 English ⚖ 506 KB